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Abstract
Background: A standardized poly-herbal decoction of Nigella sativa seeds, Hemidesmus indicus roots and Smilax
glabra rhizomes used traditionally in Sri Lanka for cancer therapy has been demonstrated previously, to have anti-
hepatocarcinogenic potential. Cytotoxicity, antioxidant activity, anti-inflammatory activity, and up regulation of p53
and p21 activities are considered to be some of the possible mechanisms through which the above decoction
may mediate its anti-hepatocarcinogenic action. The main aim of the present study was to determine whether
apoptosis is also a major mechanism by which the decoction mediates its anti-hepatocarcinogenic action.
Methods: Evaluation of apoptosis in HepG2 cells was carried out by (a) microscopic observations of cell
morphology, (b) DNA fragmentation analysis, (c) activities of caspase 3 and 9, as well as by (d) analysis of the
expression of pro-apoptotic (Bax) and anti-apoptotic (Bcl-2) proteins associated with cell death.
Results: The results demonstrated that in HepG2 cells, the decoction can induce (a) DNA fragmentation and (b)
characteristic morphological changes associated with apoptosis (nuclear condensation, membrane blebbing,
nuclear fragmentation and apoptotic bodies). The decoction could also, in a time and dose dependent manner, up
regulate the expression of the pro-apoptotic gene Bax and down regulate expression of anti-apoptotic Bcl-2 gene
(as evident from RT-PCR analysis, immunohistochemistry and western blotting). Further, the decoction significantly
(p < .001) enhanced the activities of caspase-3 and caspase-9 in a time and dose dependent manner.
Conclusions: Overall findings provide confirmatory evidence to demonstrate that the decoction may mediate its
reported anti-hepatocarcinogenic effect, at least in part, through modulation of apoptosis.
Background
A decoction prepared from a mixture of Nigella sativa
seeds, Hemidesmus indicus roots and Smilax glabra rhi-
zomes has traditionally been used for many years by a
particular family of Ayurveda physicians in Sri Lanka [1]
for the treatment of cancer patients. Findings of recent in
vivo investigations carried out by Iddamaldeniya et al.,
(2003 and 2006) indicate that this poly-herbal decoction
has the potential to significantly inhibit chemically
induced hepatocarcinogenesis [1,2]. The decoction has
been standardized considering its High Performance
Liquid Chromatography (HPLC) profile and physico-
chemical parameters according to WHO guidelines [3].
Further in vivo and in vitro investigations have demon-
strated that cytotoxicity, [3,4] antioxidant activity, anti-
inflammatory activity [5] and up regulation of p53 and
p21 activities [6] are some of the possible mechanisms
through which the above decoction may mediate its anti-
hepatocarcinogenic action.
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role in maintaining cellular homeostasis between cell
division and cell death [7,8]. An imbalance between cell
proliferation and apoptotic cell death will result in ser-
ious diseases such as cancer [9]. Cell death mediated by
apoptosis results in a series of morphological changes
such as nuclear condensation, nuclear fragmentation,
and cell surface blebbing, which leads to the formation
of membrane bound vesicles (apoptotic bodies) being
subsequently phagocytised by macrophages [10]. Apop-
tosis is regarded as the most preferred way to manage
cancer as this process does not affect neighbouring cells
like in necrosis. Apoptosis can occur through a death
receptor (extrinsic) pathway or a mitochondrial (intrin-
sic) pathway [11,12]. Both pathways will result in the
activation of caspases, a family of enzymes that act as
death effector molecules in various forms of cell death
[13]. Apoptosis has been demonstrated to be a major
mechanism employed by many natural agents [14,15] to
mediate anticancer effects.
Hepatocellular carcinoma (HCC) is one of the common-
est malignant diseases of the world, and the most frequent
primary liver cancer, with continuously increasing inci-
dence over the past decade [16]. Since the decoction com-
prised of Nigella sativa seeds, Hemidesmus indicus roots
and Smilax glabra rhizomes has been demonstrated
experimentally to possess anti-hepatocarcinogenic proper-
ties [1,2], for further development of this decoction for the
treatment of human HCC, it is important to investigate
whether apoptosis is also a major mechanism by which it
can mediate anticarcinogenic effects. Results of a prelimin-
ary flow cytometric analysis carried out recently by Thab-
rew et al., (2005) with HepG2 cells, indicated that the
above decoction may have the potential to induce apopto-
sis [4]. Therefore the present study was carried out with
the aim of obtaining further evidence to confirm that
apoptosis is indeed a major mechanism through which the
test decoction mediates its anti-hepatocarcinogenic effects.
In the present study, evaluation of apoptosis in HepG2
cells was carried out by (a) microscopic observations of
cell morphology, (b) DNA fragmentation analysis, (c)
activities of caspase 3 and 9, as well as by (d) analysis of
the expression of pro-apoptotic (Bax) and anti-apoptotic
(Bcl-2) proteins associated with cell death.
Methods
Materials and methods
HepG2 cells were purchased from ECACC, Salisbury, UK.
Dulbecco’s Modified Eagle Medium (DMEM), and TRIzol
reagent were purchased from Invitrogen, Life Technolo-
gies; U.S.A. Fetal bovine serum (FBS), streptomycin/peni-
c i l l i n ,d i m e t h y ls u l f o x i d e( D M S O ) ,a g a r o s e ,B r a d f o r d ’s
reagent and trypsin/EDTA and all other chemicals were
purchased from Sigma Aldrich (Gillingham, Dorset, UK).
M-MLV reverse transcriptase system (A3500), and GoTaq
DNA polymerase, were purchased from Promega Coop-
eration, Madisons, U.S.A. PCR primers were purchased
from Integrated DNA Technologies (IDT) U.S.A. Primary
and secondary antibodies, ABC staining kit and western
blotting luminol reagent were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). Caspase-3 and caspase-9
colorimetric kit was purchased from GenScript USA.
Collection of plant material
Plant material for the preparation of extracts and their
authentication has been previously reported (Samarakoon
et al., 2010). Plant material was purchased from a reputed
vendor of herbal material used by traditional medical prac-
titioners in Sri Lanka (D. J. Fernando Pvt Ltd, Gabose lane,
Colombo 13). Voucher specimens of N. sativa seeds,
H. indicus roots, and S.glabra rhizome (Voucher specimen
nos.UOC/IBMBB/2009/01, UOC/IBMBB/2009/02 and
UOC/IBMBB/2009/03), have been deposited at the Insti-
tute of Biochemistry, Molecular Biology & Biotechnology,
University of Colombo, Sri Lanka.
Preparation of plant decoction
The plant decoction was prepared as described previously
(Samarakoon et al., 2010). Sixty grams (60 g) of plant
material (composed of a mixture of 20 g each of N. sativa
seeds, H. indicus roots and S. glabra rhizomes) were
ground and boiled gently with 1.6 L distilled water for
approximately 3 h to reduce the volume to 200 ml. The
extract was then filtered through a layer of muslin, filtrate
centrifuged at 3000 g for 15 min to remove any debris,
and the supernatant freeze dried and stored at -20°C until
required. When required for experimental purposes, the
freeze dried extract was reconstituted with the appropriate
volume of distilled water containing 1% DMSO.
Cell culture
HepG2 cells were grown in monolayer cultures in Dulbec-
co’s Modified Eagle Medium (DMEM) supplemented with
10% fetal bovine serum, and 50 IU/ml penicillin and
50 μg/ml streptomycin. Cells were maintained at 37°C in
95% air/5% CO2 atmosphere, with 95% humidity.
Evaluation of HepG2 cell viability by MTT assay
The viability of HepG2 cells (2 × 10
5 cells/ml) incubated
with the decoction for 24 h with different doses of the
decoction were evaluated by the MTT (3-(4,5-Dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide) assay as
described previously [3].
Effects of the decoction on viability of peripheral blood
mononuclear cells
The peripheral blood mononuclear cells collected from
blood of healthy volunteers was used to evaluate effects
Samarakoon et al. BMC Complementary and Alternative Medicine 2012, 12:25
http://www.biomedcentral.com/1472-6882/12/25
Page 2 of 9of the decoction on normal (non-cancerous) human
cells. Mononuclear cells were isolated by separation in
Histopaque 1077 (Sigma). Diluted blood with Hank’s
Buffered Salt Solution (HBSS) was carefully layered onto
Histopaque 1077 and centrifuged at 1000 rpm for
10 min. After centrifugation the opaque interface con-
taining mononuclear cells were collected and washed
with phosphate buffered saline (PBS). After isolation, cells
in RPMI medium with 50 U/ml penicillin, 50 μg/ml strep-
tomycin and 10% fetal bovine serum (Sigma) were seeded
at a cell density of 2 × 10
5 cells/ml in 24 well plates. Cells
were maintained at 37°C in 95% air/5% CO2 atmosphere,
with 95% humidity. Cultures were exposed only to med-
ium containing 1% DMSO (controls) or medium contain-
ing different concentrations of decoction dissolved in 1%
DMSO (600 μg/ml -2400 μg/ml), and incubated for 24 h.
At the end of this incubation period, to determine percen-
tage of viable cells, the above cells were collected by cen-
trifugation at 150 rpm for 10 min and resuspended in
0.5 ml of RPMI medium. Cells (100 μl) were then mixed
with 1:1 dilution of (100 μl) 0.4% trypan blue solution. Cell
were counted using hemocytometer.
Isolation of total RNA and RT-PCR analysis of bax and bcl-
2 genes in HepG2 cells
HepG2 cells cultured for 24 h were incubated for 12, 24
and 48 h respectively, with fresh medium containing dif-
ferent concentrations of the decoction (test cells) or 1%
DMSO (control cells). The concentrations of decoction
used were 75, 150, 300, 600, and 1200 μg/ml, and triplicate
cell cultures were exposed to each concentration. Treated
and control cell cultures were incubated for a further 12,
24 or 48 h. At the end of the incubation period cells were
harvested and used for total RNA extraction for reverse
transcription PCR (RT- PCR).
Total RNA was isolated from the HepG2 cells, using
TRIzol reagent according to the manufacturer’s specifica-
tions. Total RNA concentration in the final elutes was
determined by using a spectrophotometer (UV-1700,
pharmasprc, SHIMADZU, Japan). Each sample of isolated
RNA was reverse transcribed by M-MLV reverse tran-
scriptase system.
Each PCR was carried out in a master mix containing
1X Green Go Taq Flexi Buffer, 2 mM MgCl2,1 0m M
dNTPs and 1.25 U GoTaq DNA polymerase (Promega
Inc. US) with 0.2 mM of respective forward and reverse
primers in 50 μl reaction mix. The PCR amplification was
carried out in a Mastercycler (Eppendrof, Hamburg,
Germany). GAPDH (glyceraldehydes 3-phosphate dehy-
drogenase) amplification was performed as an internal
control. PCR conditions for GAPDH were 30 cycles at
94°C for 30 sec, at 54°C for 30 sec at 72°C for 1 min. PCR
conditions for Bax were 35 cycles at 94°C for 1.5 min, at
55°C for 30 sec, at 72°C for 1 min. PCR conditions for
Bcl-2 were 30 cycles at 94°C for 1.5 min, at 56°C for 30 sec
at72°C for 1 min. The primers used for RT-PCR are
shown in Table 1. Amplified PCR products were subjected
to electrophoresis at 40 V through 2% agarose gel for
60 min. A 100 bp DNA ladder marker was used as a mole-
cular marker. Gels were stained with 0.5 mg/ml ethidium
bromide in TAE (Tris-acetate-EDTA) buffer. The gel
bands were examined by using a Gel Doc imaging system
and the intensity of each band was measured by using BIO
R A Dq u a n t i t yo n es o f tw a r e .S i z eo ft h ea m p l i f i e dP C R
products were 150 bp for Bax, 129 bp for Bcl-2, and
226 bp for GAPDH.
Immunohistochemistry
HepG2 cells harvested by trypsinization, and 2 × 10
5
cells/ml were plated on sterile coverslips placed in wells
of a 24 well cell culture plate. The cells (on coverslips)
were initially maintained in DMEM medium (1 ml/cover-
slip) for 24 h at 37°C in 95% air/5% CO2 atmosphere,
with 95% humidity. Cultures were then treated with the
standardized decoction (600 μg/ml or 1200 μg/ml) and
incubated for 24 h. Cells were then washed with phos-
phate buffer saline (PBS), fixed with cold 1:1 acetone:
methanol for 15 minutes and then air dried. The cover-
slips with HepG2 cells were quenched with 1% BSA in
0.05 M Tris/HCl (pH 7.6) for 30 min, and then incubated
for 60 min at 37°C with anti-Bax and anti-BCL-2 rabbit
polyclonal antibodies, diluted 1: 200. After washing with
PBS (two times), the cells were incubated for 60 min with
goat anti-rabbit IgG-HRP (diluted 1: 1000), washed again
with PBS (two times) and visualized with ABC staining
kit. Cells were counterstained with hematoxylin and
examined under a light microscope.
Western blot analysis
For in vitro evaluation of Bax and Bcl-2 proteins in HepG2
cells by western blot analysis, cells were harvested after 12,
24 and 48 h incubation with the decoction and centrifuged
at 1000 g for 10 min at 4°C. The pelleted cells were solubi-
l i z e df o r1 5m i na t4 ° Ci nl y sis buffer [50 mM Tris-HCl
pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40,
0.25% Na-deoxycholate, 1 mM PMSF (phenylmethylsulfo-
nyl fluoride) and proteinase inhibitor cocktail]. Lysates
were centrifuged at 12,000g for 15 min at 4°C to remove
Table 1 Primer sequences used for RT PCR
Name of Primer Primer sequence
Bax : forward primer 5’-GGACGAACTGGACAGTAACATGG-3’
Bax : reverse primer 5’-GCAAAGTAGAAAAGGGCGACAAC-3’
Bcl-2: forward primer 5’-ATCGCCCTGTGGATGACTGAG-3’
Bcl-2: reverse primer 5’- CAGCCAGGAGAAATCAAACAGAGG-3’
GAPDH: forward primer 5’-GAAGGTGAAGGTCGGAGTC-3’
GAPDH: reverse primer 5’-GAAGATGGTGATGGGATTTC-3’
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tein concentration was determined using the Bradford’s
reagent. For Western blot analysis, samples (40 μg each)
were separated by electrophoresis on 10% SDS-polyacryla-
mide gels and transferred onto nitrocellulose membranes.
The nitrocellulose membranes onto which proteins were
transferred were pre-blocked with 5% non fat dry milk in
PBS for 30 min and then incubated for 16 h at 4°C with
specific primary antibodies. After three washes of 10 min
each with 1× TBST (50 mM Tris-HCl, pH7.4, 150 mM
NaCl, 1% Tween 20), each membrane was incubated with
the secondary antibody for 30 min at room temperature.
The membrane was then washed three times with TBST
(10 min/wash) and bands visualized using western blotting
luminol reagent system. Bands were normalized using b-
actin antibody.
Detection of morphological changes related to apoptosis
by light microscopy
HepG2 cells (2 × 10
5 cells/ml) cultured in 24 well cell
culture plates were exposed to different concentrations
(0-1800 μg/ml) of the decoction (test cells) or 1% DMSO
(control cells) respectively for further 24 h. Morphologi-
cal changes of the cells were then observed under a
inverted light microscope (Olympus CKX41SF, Japan).
Detection of morphological changes related to apoptosis by
fluorescent microscopy
HepG2 cells were seeded at a final concentration of 2 ×
10
5 cells/ml in 6-well culture plates the night before the
treatment for apoptosis detection by acridine orange/
ethidium bromide (AO/EB) staining and Hoechst 33258
staining. The cells were exposed to different concentra-
tions of the decoction (0-1800 μg / m l )( t e s tc e l l s )o r1 %
DMSO (control cells) respectively for 24 h. After incuba-
tion, control and treated cells were harvested by trypsini-
zation, centrifuged and suspended in PBS at a final
concentration of 1 × 10
5 cells/ml. The cells were fixed by
4% formaldehyde at room temperature and plated onto
glass slides and subjected to apoptosis analysis by acri-
dine orange/ethidium bromide (AO/EB) staining and
Hoechst 33258 staining as described below.
Acridine orange/ethidium bromide (AO/EB) staining
The AO/EB staining was carried out according to Ribble
et al. (2005) [17]. Fluorescent dyes, ethidium bromide
(100 μg/ml) and acridine orange (100 μg/ml) were added
to the fixed cells and incubated for 10 min at room tem-
perature in dark. Changes in the nuclei of cells within
15 min. after AO/EB staining were observed under a
fluorescence microscope (Olympus, BX51TRF, Japan).
Morphological criteria were used to evaluate cell injury.
Cells containing normal nuclear chromatin exhibit green
nuclear staining. Cells containing fragmented nuclear
chromatin due to apoptosis exhibit orange to red nuclear
staining.
Hoechst 33258 staining
Characteristic apoptotic morphological changes were
assessed by fluorescent microscopy using bis-benzimide
(Hoechst 33258) staining. Fixed cells were stained with
200 μL of bis-benzimide (5 μg/mL) for 10 min at room
temperature. Then, 10 μL of this suspension was placed
on a glass slide and covered with a cover slip. The cells
were examined using a fluorescence microscope (Olympus
BX51TRF, Japan), to determine nuclei fragmentation and
chromatin condensation.
DNA fragmentation analysis
Agarasose gel electrophoresis was used to detect the char-
acteristic ladder pattern of DNA fragmentation as
described by Yang et al. (2000) with slight modifications.
Cells (2 × 10
5 cells/ml) exposed to the standardized decoc-
tion and positive control (thymoquinone) for 24 and 48 h
were gently scraped and harvested by centrifugation. The
cell pellets were incubated for 60 min at 50°C in 100 μl
lysis buffer (100 mM Tris-HCl pH 8, 100 mM NaCl and
10 mM EDTA). Proteinase K (10 μl 20 mg/ml stock solu-
tion) was then added to the lysis mixture and further incu-
bated for 30 min at 50°C. RNase (3 μlf r o m1 0m g / m l
stock solution) was then added and the mixture incubated
for 2 h at 50°C. DNA was extracted with phenol-chloro-
form-isoamyl alcohol, subjected to 2.0% of agarose gel
electrophoresis, stained with ethidium bromide and visua-
lized under UV light using a gel-doc system (Quantum-
ST4 1100/20 M).
Caspase 3 and caspase 9 activities
Caspase activities were determined by colorimetric assays
using caspase-3, and -9 activation kits (GenScript USA)
according to the manufacturer’s protocol. The kits are
based on spectrophotometric detection of the chromo-
phore pnitroaniline (pNA) after cleavage from the labeled
substrate DEVD-pNA. HepG2 cells (2 × 10
5 cells/ml) were
incubated with different concentrations of the decoction
(600 μg/ml and 1200 μg/ml) for 24, and 48 h. Cells were
then harvested by trypsinization, washed twice with ice-
cold PBS buffer (pH 7.4) and lysed in the supplied lysis
buffer containing dithiothreitol (DTT). The supernatant
was collected and protein concentration determined using
Bradford’s reagent. Equal amount of protein (100 μg) was
incubated with the supplied reaction buffer containing
dithiothreitol (DTT) and substrates (5 μl) at 37°C for 4 h.
The caspase activity was determined by measuring
changes in absorbance at 405 nm using the Micro plate
reader (ELx 800 Universal Microplate Reader, BIO-TEK
INSTRUMENTS, USA).
Statistical analysis
Results of RT-PCR were analyzed using Prism 2.01
(Graphpad Prism, San Diego, CA). Two way ANOVA
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decoction and duration of the treatment on the mRNA
expression of Bax and Bcl-2 in HepG2 cells. One way
analysis of variance (One way ANOVA) with Dunnett’s
post test for multiple comparisons was used to find out
the concentrations at which the Bax expression was sig-
nificantly increased while reducing the expression of
Bcl-2 in comparison to controls. Effect of the decoction
on caspase activities was analysed by using one way
ANOVA with Banforroni post test.
Results
RT-PCR analysis of bax and bcl-2 gene expression in
HepG2 cells
Bax and Bcl-2 gene expression were normalized to the
house keeping GAPDH gene. As evident from Figure 1A,
B, Additional file: Figure S1, and Table 2, RT-PCR evalua-
tion of HepG2 cells treated with different concentrations
of the decoction (75 μg/ml - 1200 μg/ml) showed in a sig-
nificant (P < 0.001) dose and time dependent increase in
Bax mRNA expression along with a significant (P < 0.001)
decrease in Bcl-2 mRNA expression.
Immunohistochemical analysis and western blot analysis
of bax and bcl-2 in HepG2 cells
As evident from Figure 2A and 2B, immunohistochemical
analysis of Bax and Bcl-2 proteins confirmed the results
from RT-PCR analysis of Bax and Bcl-2 mRNA expression
in HepG2 cells. Expression of Bax was increased and Bcl-2
was decreased in treated samples when compared to con-
trol samples. In western blot analysis Bax and Bcl-2 gene
expression were normalized to the house keeping b-actin
protein. In support of results obtained by immunohisto-
chemistry and RT-PCR, results of the western blot analysis
of Bax and Bcl-2 expression in HepG2 cells (2 × 10
5 cells/
ml) treated with different concentrations (0-1200 μg/ml) of
the standardized decoction (for 12, 24 and 48 h) also
resulted in a time and dose dependent up regulation of Bax
along with a down regulation of Bcl-2 (Figure 2C.).
Detection of cell viability, changes related to apoptosis
and DNA fragmentation analysis
Effects of the decoction on cell viability in HepG2 cells
and peripheral blood mononuclear cells were compared.
As evident from Figure 3A, less anti-proliferative effect on
normal PBM cells was observed when compared to the
effect of the decoction in HepG2 cells. Characteristic
apoptotic morphological changes of HepG2 cells were
assessed by the light and fluorescent microcopy (Figure 3B
and 3C). Fluorescent microscopic examination of HepG2
cells after AO/EB staining (Figure 3C) revealed nuclear
condensation, membrane blebbing, nuclear fragmentation
and apoptotic bodies (the hallmarks of apoptosis) in cells
that had been incubated with the decoction. The number
of cells with orange to red nuclear staining increased with
increase in the dose of decoction. The control cells did not
exhibit any of the above morphological changes. Chroma-
tin condensation and other apoptotic characters were
observed only in the treated cells and not in the control
Figure 1 Effects of the decoction on mRNA expression of Bax
and Bcl-2 in HepG2 cells treated with the decoction for 12, 24,
and 48 h. Data values are expressed as mean ± SEM of triplicate
determinations. Significant differences were compared to the
control at p* <.01 by ANOVA with Dunnett’s post test for different
time points and Two way ANOVA analysis was used to detect the
effect of different concentrations of the decoction and duration of
the treatment on the mRNA expression of Bax and Bcl-2 in HepG2
cells.
Table 2 Bax/Bcl-2 ratio of mRNA expression
Dose of the decotion Bax/Bcl-2
12 h 24 h 48 h
Control 0.484 0.489 0.468
75 μg/ml 0.603 0.663 0.827
150 μg/ml 0.758 0.920 1.020
300 μg/ml 1.074 1.220 1.410
600 μg/ml 1.660 1.886 2.180
1200 μg/ml 2.254 2.792 3.857
Bax/Bcl-2 ratio was up regulated in a time and dose dependent manner
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fragmentation (ladder pattern) characteristic of apoptosis
was observed in HepG2 cells (2 × 10
5 cells/ml) exposed to
the standardized decoction for 24 and 48 h. Control cells
not exposed to the decoction, showed no evidence of
DNA fragmentation (Figure 3E).
Effect of the decoction on the expression of caspase 3
and caspase 9 in HepG2 cells
As shown in Figure 4 decoction increased the activation of
caspase-3 and caspase-9 in HepG2 cells at concentration
of 600 μg/ml and 1200 μg/ml in a significant (p < 0.001)
time and dose dependent manner.
Discussion
Previous in vivo and in vitro investigations [1,2] have
shown that the decoction, comprised of N. sativa seed,
H. indicus root, and S. glabra, can mediate anti-hepatocar-
cinogenic effects, without producing any significant toxic
side effects. The antihepatocarcinogenic effects of the
decoction probably results from an impact of this polyher-
bal formulation on a broad range of biochemical activities
including antioxidant activity [5], anti-inflammatory activ-
ity, immunomodulatory activity and modulation of activ-
ities of factors involved in cell proliferation and cell cycle
arrest [3,4,6]. In the study carried out by Thabrew et al.,
(2005), a flow cytometric analysis of HepG2 cells exposed
to the test decoction indicated that this polyherbal formu-
lation also has the potential to induce apoptosis.
Results obtained in the present investigation confirm that
apoptosis could indeed be a major mechanism through
which the decoction mediates its anti-hepatocarcinogenic
effect. Typical features of apoptosis such as chromatin con-
densation, and nuclear fragmentation were clearly evident
in decoction treated HepG2 cells from light microscopic
and fluorescent microscopic studies and DNA fragmenta-
tion analysis by agarose gel electrophoresis.
Two major pathways (the extrinsic and intrinsic path-
ways) regulate apoptosis. Both pathways converge to a
common pathway involving the activation of a cascade of
proteases named caspases that cleave regulatory and struc-
tural molecules, culminating in cell death. Caspases are the
central components of the apoptotic response and a con-
served family of enzymes that irreversibly commit a cell to
die. They are cysteine proteases that cleave substrates after
specific aspartate residues. The apoptotic caspases which
are involved in the regulation and execution of apoptosis
are generally divided into two classes: the initiator cas-
pases, which include caspase- 2, -8, -9 and -10 and the
effector caspases, which include caspases-3, -6 and -7
[18,19].
Due to differences in sensitivity, tumours are consid-
ered to arise more frequently through the intrinsic path-
way than the extrinsic pathway [20]. Transmembrane
Figure 2 Immunohistochemistry and Western blot analysis. Immunohistochemical analysis analysis of expression of Bax [A] and Bcl-2 [B]
protein in HepG2 cells (shown by arrows). [a] control (untreated) [b] treated with the decoction (600 μg/ml), [c] treated with the decoction
(1200 μg/ml). Section [d] represents the negative control. Hematoxyline was used for counterstaining. [C] Western blot analysis of effects of the
decoction on Bax and Bcl-2 expression in HepG2 cells treated with different concentrations (lane 1-control, lane 2-300 μg/ml, lane 3-600 μg/ml,
lane 4-1200 μg/ml) of the standardized decoction at (a) 12 h post incubation, (b) 24 h post-incubation and (c) 48 h post incubation was
performed as described in the Materials and Methods section. Normalization of bands was performed using b-actin protein.
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receptors (such as Fas), which are members of the
tumour necrosis factor (TNF) receptor gene superfamily
[21], are reported to be involved in initiation of apoptosis
by the extrinsic pathway. In contrast, initiation of apopto-
sis by the intrinsic pathway involves a diverse array of
non-receptor mediated stimuli. These stimuli produce
intracellular signals that act directly on targets within the
cell and are mitochondrial initiated events [22]. The
release of mitochondrial proteins such as cytochrome c,
promotes the assembly of a caspase - activating complex
(the apoptosome) which in turn can induce activation of
caspase-9 and thereby initiate the caspase cascades parti-
cipating in apoptosis [23,24]. Caspase -9, the initiator
protein, is considered to be an essential element in the
intrinsic pathway of apoptosis [23]. Caspase - 3, is
reported to be the promoter of apoptosis. Results of the
present study demonstrate that the decoction under
Figure 3 Detection of morphological changes related to apoptosis and DNA fragmentation analysis. Data are representative one of three
similar experiments. Induction of decoction on morphological changes, apoptotic bodies formation and DNA fragmentation in HepG2 cells. The
cells were treated with indicated dose of decoction for 24 h and (A) anti-proliferative effect on PBM cells and HepG2 cells (B) photographed by
phase contrast microscope. (C) The cells were stained with acridine orange/ethidium bromide and visualized for nuclear morphology and
apoptotic bodies under fluorescent microscope using a blue filter (D) The cells were stained with Hoechst 33258 and visualized for nuclear
morphology and apoptotic bodies under fluorescent microscope using a blue filter (E) Fragmented DNA was extracted and analyzed on 2%
agarose gel electrophoresis.
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both caspase-3 and caspase-9 in HepG2 cells in a time
and dose dependent manner.
It is well known that apoptosis is tightly regulated by
changes in the expression of specific genes. Fas and Bcl2
families of genes are the best known among the factors
that modulate cancer related apoptosis. Fas binding to its
ligand FasL results in the initiation of active caspase-8
that can activate caspase-3 and induce cell apoptosis [25].
The Bcl-2 family of proteins is divided into three subfa-
milies and pro-apoptotic and anti-apoptotic members
have a major role in the regulation of cell death. The
anti-apoptotic subfamily comprises of Bcl-2, Bcl-xL, Bcl-
w, Mcl-1, A1 (Bfl-1), and Bcl-B proteins and pro apopto-
tic subfamily consists of Bax, Bak, Mtd (Bok), and Bcl
rambo. Anti-apoptotic members of the Bcl-2 family
(among which Bcl-2 is of particular significance), inhibit
the release of these apoptogenic factors, whereas pro-
apoptotic members such as Bax, promote its release [26].
Both Bax and Bcl-2 play pivotal roles in caspase activa-
tion and the regulation of apoptosis [27,28]. In the pre-
sent study we have demonstrated that in HepG2 cells, in
response to the decoction comprising of N. sativa seed,
H. indicus root, and S. glabra, transcription (as demon-
strated by RT-PCR) and translation (as demonstrated by
immunohistochemistry and western blot analysis) of pro
apoptotic Bax gene are significantly enhanced while the
transcription and translation of anti apoptotic Bcl-2 gene
are significantly reduced.
Overall results obtained indicate that apoptosis is a
probable mechanism through which the decoction
under test mediates its anti-hepatocarcinogenic effect.
To determine the actual percentage of apoptosis a FACS
analysis using Annexin- V (FTC conjugated) needs to be
conducted. Apoptosis induced by the decoction may be
regulated by pro-apoptotic and anti-apoptotic protein
members of the Bcl-2 family and is executed through
two major caspase pathways, the mitochondria-depen-
dent “intrinsic” cytochrome c/caspase- 9 and caspase-3
pathway.
Conclusions
In conclusion, the present study demonstrates that the
decoction of Nigella sativa seeds, Hemidesmus indicus
roots and Smilax glabra rhizomes can induce apoptosis
in human hepatocellular carcinoma HepG2 cell, in a
dose and time dependent manner through the activation
of caspase-3 and caspase-9, and up regulation of pro-
apoptotic Bax and down regulation of anti-apoptotic
Bcl-2 genes which are involved in intrinsic or mitochon-
drial pathway of apoptosis.
Additional material
Additional file 1: Figure S1 Effects of the decoction on mRNA
expression of Bax and Bcl-2 in HepG2 cells treated with the
decoction for 12, 24, and 48 h.
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